|Affiliation||Institute of Molecular and Clinical Ophthalmology Friedrich Miescher Institute University of Basel, Switzerland|
|Time||Friday, 17 January, 2020, 11:00 am - 12:00 pm|
|Location||imec Tower room 1B|
|Registration||External participants, please register|
To find ways to repair visual dysfunction, the Roska lab investigates the retina, thalamus and cortex at the level of cell types and circuits. The knowledge they are acquiring has already improved our understanding of disease mechanisms and opened paths to potential treatments.
The Roska Lab work illustrates how insights into the organization of the cell types and circuits of the nervous system, when combined with cellular engineering, could be used to design new therapies to fight blindness.
Prof. Roska obtained his MD at the Semmelweis Medical School, a PhD in neurobiology from the University of California, Berkeley and studied genetics and virology at Harvard University and the Harvard Medical School.
He established a research group at the Friedrich Miescher Institute in Basel in 2005.
In 2010 he became Professor at the Medical Faculty of the University of Basel and he is now founding director of the Institute of Molecular and Clinical Ophthalmology Basel (IOB).